Present value of the Urethral mobility test as a tool to assess Stress urinary incontinence due to Intrinsic sphincteric deficiency.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
02 12 2020
Historique:
received: 01 10 2019
accepted: 12 03 2020
entrez: 3 12 2020
pubmed: 4 12 2020
medline: 15 1 2021
Statut: epublish

Résumé

Q-tip test offers a simple approach for identifying urethral hypermobility. Considering surgical treatment, stress urinary incontinence (SUI) must be classified and the contribution of intrinsic sphincter deficiency (ISD) and/or urethral hypermobility must be determine. We believe there's a correlation between abdominal leak point pressure (ALPP) and urethral mobility degree, and the aim of this study is to explore it using Q-tip. We conducted a prospective study, between years 2014 and 2016. Females over 18 years presenting with signs and symptoms of SUI according to the 2002 ICS Standardization of Terminology were included. Assessment was made with the International Consultation on Incontinence Questionnaire Short Form (ICIQ-SF), the Q-tip test and invasive urodynamics. Urethral mobility (UM) and ALPP were analyzed. We built two composite variables based on reported risk factors for ISD, defined as composite variable A (equal to a Q-tip test < 30° AND ICIQ-SF ≥ 10 points) and composite variable B (equal to low urethral mobility AND/OR hypoestrogenism AND/OR history of radiotherapy AND/OR previous pelvic surgery). Correlation analyzes were made according to the type of variable. A total of 221 patients were included. Incontinence was rated as moderate and severe by 65.3% and 6.8%, respectively. The analysis showed a 61.75%, 51.61% and 70.6% agreement between ALPP and UM, ALPP and composite variable A and ALPP and composite variable B respectively. Correlation and concordances were low (r = 0.155, r_s = - 0.053 and r_s = - 0.008), (rho_c = 0.036, k = 0.116 and k = 0.016). Neither the degree of UM, nor the composite variables, correlate or agree with urethral function tests in UDS, suggesting that the ALPP cannot be predicted using the Q-tip test or the ICIQ-SF for classifying patients with SUI.

Identifiants

pubmed: 33268806
doi: 10.1038/s41598-020-77493-1
pii: 10.1038/s41598-020-77493-1
pmc: PMC7710709
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

20993

Références

J Urol. 2003 Mar;169(3):999-1002
pubmed: 12576830
Chirurgia (Bucur). 2014 May-Jun;109(3):359-68
pubmed: 24956342
J Urol. 2017 Oct;198(4):875-883
pubmed: 28625508
Int J Urol. 2017 Jul;24(7):548-552
pubmed: 28556438
Am J Obstet Gynecol. 1996 Jul;175(1):10-7
pubmed: 8694033
Obstet Gynecol. 1971 Aug;38(2):313-5
pubmed: 5105346
Prog Clin Biol Res. 1981;78:351-60
pubmed: 7335750
N Engl J Med. 2010 Jun 3;362(22):2066-76
pubmed: 20479459
J Urol. 1988 Apr;139(4):727-31
pubmed: 3352031
Neurourol Urodyn. 2002;21(2):167-78
pubmed: 11857671
J Midlife Health. 2016 Jul-Sep;7(3):119-125
pubmed: 27721639
J Urol. 1997 Sep;158(3 Pt 1):875-80
pubmed: 9258103
Low Urin Tract Symptoms. 2019 Apr;11(2):O117-O120
pubmed: 29938931
J Appl Res. 2008;8(1):
pubmed: 24772006
J Urol. 1993 Nov;150(5 Pt 1):1452-4
pubmed: 8411422
Neurourol Urodyn. 2017 Jun;36(5):1243-1260
pubmed: 27917521
Int Urogynecol J. 2010 Aug;21(8):963-7
pubmed: 20379698
Neurourol Urodyn. 2007;26(3):392-6
pubmed: 17304525
Int Braz J Urol. 2012 Sep-Oct;38(5):667-73
pubmed: 23131507
Int Urol Nephrol. 2014 Nov;46(11):2103-8
pubmed: 25315465
J Urol. 1996 Dec;156(6):1995-8
pubmed: 8911373
Neurourol Urodyn. 2002;21(3):261-74
pubmed: 11948720
Neurourol Urodyn. 2010;29(1):4-20
pubmed: 19941278
Int Urogynecol J Pelvic Floor Dysfunct. 2008 Jan;19(1):5-33
pubmed: 18026681
Eur J Obstet Gynecol Reprod Biol. 2010 Jul;151(1):14-9
pubmed: 20236751
Am J Obstet Gynecol. 1988 Jul;159(1):145-9
pubmed: 3394734
Obstet Gynecol. 1988 Jun;71(6 Pt 1):807-11
pubmed: 3368164
J Reprod Med. 1990 Jan;35(1):68
pubmed: 2299616
Can Urol Assoc J. 2017 Jun;11(6Suppl2):S113-S115
pubmed: 28616106
BJU Int. 2005 Aug;96(3):232-3
pubmed: 16042706
J Urol. 2004 May;171(5):1871-5
pubmed: 15076296

Auteurs

Daniela Robledo (D)

Department of Urology, Hospital Universitario Fundación Santa Fe de Bogotá and Universidad de Los Andes School of Medicine, Carrera 7 No. 118-09, Unidad Renal, piso 3, 110111, Bogotá, D.C., Colombia.

Laura Zuluaga (L)

Department of Urology, Hospital Universitario Fundación Santa Fe de Bogotá and Universidad de Los Andes School of Medicine, Carrera 7 No. 118-09, Unidad Renal, piso 3, 110111, Bogotá, D.C., Colombia.

Alejandra Bravo-Balado (A)

Department of Urology, Hospital Universitario Fundación Santa Fe de Bogotá and Universidad de Los Andes School of Medicine, Carrera 7 No. 118-09, Unidad Renal, piso 3, 110111, Bogotá, D.C., Colombia.

Cristina Domínguez (C)

Department of Urology, Hospital Universitario Fundación Santa Fe de Bogotá and Universidad de Los Andes School of Medicine, Carrera 7 No. 118-09, Unidad Renal, piso 3, 110111, Bogotá, D.C., Colombia.

Carlos Gustavo Trujillo (CG)

Department of Urology, Hospital Universitario Fundación Santa Fe de Bogotá and Universidad de Los Andes School of Medicine, Carrera 7 No. 118-09, Unidad Renal, piso 3, 110111, Bogotá, D.C., Colombia.

Juan Ignacio Caicedo (JI)

Department of Urology, Hospital Universitario Fundación Santa Fe de Bogotá and Universidad de Los Andes School of Medicine, Carrera 7 No. 118-09, Unidad Renal, piso 3, 110111, Bogotá, D.C., Colombia.

Martín Rondón (M)

Department of Clinical Epidemiology and Biostatistics, Pontificia Universidad Javeriana, Bogotá, D.C., Colombia.

Julián Azuero (J)

Department of Urology, Hospital Universitario Fundación Santa Fe de Bogotá and Universidad de Los Andes School of Medicine, Carrera 7 No. 118-09, Unidad Renal, piso 3, 110111, Bogotá, D.C., Colombia.

Mauricio Plata (M)

Department of Urology, Hospital Universitario Fundación Santa Fe de Bogotá and Universidad de Los Andes School of Medicine, Carrera 7 No. 118-09, Unidad Renal, piso 3, 110111, Bogotá, D.C., Colombia. mplata@uniandes.edu.co.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH